(Q55234480)

28 June 2018

title

Cytotoxicity of amrubicin, a novel 9-aminoanthracycline, and its active metabolite amrubicinol on human tumor cells. (English)

1 reference

28 June 2018

0 references

T Yamaoka

1

1 reference

28 June 2018

M Hanada

2

1 reference

28 June 2018

S Ichii

3

1 reference

28 June 2018

S Morisada

4

1 reference

28 June 2018

T Noguchi

5

1 reference

28 June 2018

Y Yanagi

6

1 reference

28 June 2018

publication date

1 October 1998

1 reference

28 June 2018

number of pages

7

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

28 June 2018

volume

89

1 reference

28 June 2018

issue

10

1 reference

28 June 2018

page(s)

1067-1073

1 reference

28 June 2018

Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921698

Antitumor activities of a novel 9-aminoanthracycline (SM-5887) against mouse experimental tumors and human tumor xenografts

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921698

Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921698

Plasma pharmacokinetics and cerebrospinal fluid concentrations of idarubicin and idarubicinol in pediatric leukemia patients: a Childrens Cancer Study Group report.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921698

Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921698

Comparison of antitumor activity of new anthracycline analogues, ME2303, KRN8602, and SM5887 using human lung cancer cell lines.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921698

Anthracycline antibiotic pharmacology and metabolism

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921698

Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cells.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921698

In vivo efficacy and tumor-selective metabolism of amrubicin to its active metabolite.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921698

Protection against daunorubicin cytotoxicity by expression of a cloned human carbonyl reductase cDNA in K562 leukemia cells.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921698

DNA damage and cytotoxicity induced by metabolites of anthracycline antibiotics, doxorubicin and idarubicin

13 August 2018

1 reference

12 December 2020

Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit

1 reference

12 December 2020

Different cytotoxicity and metabolism of doxorubicin, daunorubicin, epirubicin, esorubicin and idarubicin in cultured human and rat hepatocytes

1 reference

12 December 2020

Comparative metabolism of daunorubicin and 4-demethoxydaunorubicin in mice and rabbits

1 reference

12 December 2020

Uptake and metabolism of daunorubicin by human myelocytic cells

1 reference

12 December 2020

A high performance liquid chromatographic method of analysis of 4'-O-tetrahydropyranyladriamycin and their metabolites in biological samples

1 reference

12 December 2020

Pharmacokinetics of doxorubicin in sarcoma patients

1 reference

12 December 2020

Adriamycin uptake and metabolism in organotypic culture of A549 human adenocarcinoma cells according to the exposure time

1 reference

12 December 2020

Pharmacokinetics of 4-demethoxydaunorubicin in cancer patients

1 reference

12 December 2020

Uptake and intracellular distribution of doxorubicin metabolites in B-lymphocytes of chronic lymphocytic leukemia

1 reference

12 December 2020

Inhibition of human ovarian cancer colony formation by adriamycin and its major metabolites

1 reference

12 December 2020

Metabolism of doxorubicin, daunorubicin and epirubicin in human and rat hepatoma cells

1 reference

12 December 2020

Daunorubicin and daunorubicinol pharmacokinetics in plasma and tissues in the rat

1 reference

12 December 2020

10.1111/J.1349-7006.1998.TB00498.X

Identifiers

DOI

1 reference

28 June 2018

PMC publication ID

5921698

1 reference

28 June 2018

PubMed publication ID

9849587

1 reference

28 June 2018